Karl R. VanDerMeid

1.0k total citations
27 papers, 839 citations indexed

About

Karl R. VanDerMeid is a scholar working on Radiology, Nuclear Medicine and Imaging, Immunology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Karl R. VanDerMeid has authored 27 papers receiving a total of 839 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Radiology, Nuclear Medicine and Imaging, 10 papers in Immunology and 7 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Karl R. VanDerMeid's work include Ocular Surface and Contact Lens (7 papers), Corneal Surgery and Treatments (6 papers) and Chronic Lymphocytic Leukemia Research (6 papers). Karl R. VanDerMeid is often cited by papers focused on Ocular Surface and Contact Lens (7 papers), Corneal Surgery and Treatments (6 papers) and Chronic Lymphocytic Leukemia Research (6 papers). Karl R. VanDerMeid collaborates with scholars based in United States, France and Netherlands. Karl R. VanDerMeid's co-authors include Keith W. Ward, John McMichael, Jin-Zhong Zhang, Megan E. Cavet, Vicki Barniak, Karen Harrington, Clive S. Zent, Dexiang Chen, Russell Hilf and Gibson Sl and has published in prestigious journals such as Blood, The Journal of Immunology and Journal of Cell Science.

In The Last Decade

Karl R. VanDerMeid

25 papers receiving 798 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karl R. VanDerMeid United States 16 227 204 189 175 144 27 839
Marco Messina Italy 18 129 0.6× 181 0.9× 84 0.4× 52 0.3× 152 1.1× 78 1.1k
Lynne M. Mitchell United States 15 75 0.3× 88 0.4× 76 0.4× 700 4.0× 55 0.4× 28 989
Soo Jung Han South Korea 16 313 1.4× 146 0.7× 159 0.8× 239 1.4× 51 0.4× 30 793
J N Goldman United States 16 140 0.6× 261 1.3× 73 0.4× 183 1.0× 19 0.1× 36 762
Salim I. Butrus United States 19 719 3.2× 246 1.2× 107 0.6× 281 1.6× 42 0.3× 40 1.3k
You‐Qiang Wu United States 10 75 0.3× 72 0.4× 48 0.3× 549 3.1× 30 0.2× 12 765
Mei Zheng United States 19 246 1.1× 235 1.2× 525 2.8× 487 2.8× 76 0.5× 30 1.3k
M Vuento Finland 14 144 0.6× 138 0.7× 74 0.4× 100 0.6× 87 0.6× 21 1.2k
Romela Irene Ramos United States 17 64 0.3× 36 0.2× 136 0.7× 631 3.6× 69 0.5× 27 1.4k
Zsuzsa Bajtay Hungary 24 57 0.3× 129 0.6× 134 0.7× 886 5.1× 34 0.2× 46 1.3k

Countries citing papers authored by Karl R. VanDerMeid

Since Specialization
Citations

This map shows the geographic impact of Karl R. VanDerMeid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karl R. VanDerMeid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karl R. VanDerMeid more than expected).

Fields of papers citing papers by Karl R. VanDerMeid

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karl R. VanDerMeid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karl R. VanDerMeid. The network helps show where Karl R. VanDerMeid may publish in the future.

Co-authorship network of co-authors of Karl R. VanDerMeid

This figure shows the co-authorship network connecting the top 25 collaborators of Karl R. VanDerMeid. A scholar is included among the top collaborators of Karl R. VanDerMeid based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karl R. VanDerMeid. Karl R. VanDerMeid is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Menzel, Thomas, et al.. (2021). Comparative analysis of the osmoprotective effects of a novel contact lens packaging solution on human corneal epithelial cells. Investigative Ophthalmology & Visual Science. 62(8). 672–672. 1 indexed citations
3.
Chu, Charles C., Jonathan J. Pinney, Fátima Rivera‐Escalera, et al.. (2020). High-resolution quantification of discrete phagocytic events by live cell time-lapse high-content microscopy imaging. Journal of Cell Science. 133(5). 9 indexed citations
4.
Pinney, Jonathan J., Fátima Rivera‐Escalera, Charles C. Chu, et al.. (2020). Macrophage hypophagia as a mechanism of innate immune exhaustion in mAb-induced cell clearance. Blood. 136(18). 2065–2079. 25 indexed citations
5.
Oostindie, Simone C., Hilma J. van der Horst, Margaret A. Lindorfer, et al.. (2019). CD20 and CD37 antibodies synergize to activate complement by Fc-mediated clustering. Haematologica. 104(9). 1841–1852. 40 indexed citations
6.
VanDerMeid, Karl R., Michael R. Elliott, Andrea Baran, et al.. (2018). Cellular Cytotoxicity of Next-Generation CD20 Monoclonal Antibodies. Cancer Immunology Research. 6(10). 1150–1160. 56 indexed citations
7.
Chu, Charles C., Karl R. VanDerMeid, Michael R. Elliott, et al.. (2018). Antibody-dependent cellular phagocytosis is responsible for efficacy of anti-CD20 monoclonal antibody therapy in chronic lymphocytic leukemia. The Journal of Immunology. 200(Supplement_1). 56.4–56.4. 4 indexed citations
8.
Taylor, Ronald P., Margaret A. Lindorfer, Erika M. Cook, et al.. (2017). Hexamerization-enhanced CD20 antibody mediates complement-dependent cytotoxicity in serum genetically deficient in C9. Clinical Immunology. 181. 24–28. 11 indexed citations
9.
VanDerMeid, Karl R., et al.. (2015). Anti-CD20 monoclonal antibody-dependent phagocytosis of chronic lymphocytic leukaemia cells by autologous macrophages. Clinical & Experimental Immunology. 183(1). 90–101. 34 indexed citations
10.
Cavet, Megan E., Thomas Vollmer, Karen Harrington, Karl R. VanDerMeid, & Mary Richardson. (2014). NO-induced Regulation of Primary Human Trabecular Meshwork Cell Contractility by Latanoprostene Bunod. Investigative Ophthalmology & Visual Science. 55(13). 546–546. 1 indexed citations
11.
Cavet, Megan E., et al.. (2012). In vitro biocompatibility assessment of multipurpose contact lens solutions: Effects on human corneal epithelial viability and barrier function. Contact Lens and Anterior Eye. 35(4). 163–170. 13 indexed citations
12.
VanDerMeid, Karl R., et al.. (2012). Correlation of Tear Inflammatory Cytokines and Matrix Metalloproteinases with Four Dry Eye Diagnostic Tests. Investigative Ophthalmology & Visual Science. 53(3). 1512–1512. 73 indexed citations
13.
VanDerMeid, Karl R., et al.. (2011). A method to extract cytokines and matrix metalloproteinases from Schirmer strips and analyze using Luminex.. PubMed. 17. 1056–63. 66 indexed citations
14.
Cavet, Megan E., et al.. (2010). Effect of a novel multipurpose contact lens solution on human corneal epithelial barrier function. Contact Lens and Anterior Eye. 33. S18–S23. 21 indexed citations
15.
Cavet, Megan E., Karen Harrington, Karl R. VanDerMeid, Keith W. Ward, & Jin-Zhong Zhang. (2009). Comparison of the effect of multipurpose contact lens solutions on the viability of cultured corneal epithelial cells. Contact Lens and Anterior Eye. 32(4). 171–175. 40 indexed citations
16.
Zhang, Jin Z., Megan E. Cavet, Karl R. VanDerMeid, et al.. (2009). BOL-303242-X, a novel selective glucocorticoid receptor agonist, with full anti-inflammatory properties in human ocular cells.. PubMed. 15. 2606–16. 45 indexed citations
17.
Bucolo, Claudio, et al.. (2008). Levocabastine Inhibits Cytokine Release From Eosinophils. Investigative Ophthalmology & Visual Science. 49(13). 412–412. 1 indexed citations
18.
Fiske, Michael J., Ross A. Fredenburg, Karl R. VanDerMeid, John McMichael, & Rasappa Arumugham. (2001). Method for reducing endotoxin in Moraxella catarrhalis UspA2 protein preparations. Journal of Chromatography B Biomedical Sciences and Applications. 753(2). 269–278. 22 indexed citations
19.
McMichael, John, et al.. (1999). Evaluation of a 74-kDa transferrin-binding protein from Moraxella (Branhamella) catarrhalis as a vaccine candidate. Vaccine. 18(1-2). 109–118. 16 indexed citations
20.
Sl, Gibson, et al.. (1990). Effects of various photoradiation regimens on the antitumor efficacy of photodynamic therapy for R3230AC mammary carcinomas.. PubMed. 50(22). 7236–41. 92 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marco Messina Breakdown of academic impact, for papers by Lynne M. Mitchell Breakdown of academic impact, for papers by Soo Jung Han Breakdown of academic impact, for papers by J N Goldman Breakdown of academic impact, for papers by Salim I. Butrus Breakdown of academic impact, for papers by You‐Qiang Wu Breakdown of academic impact, for papers by Mei Zheng Breakdown of academic impact, for papers by M Vuento Breakdown of academic impact, for papers by Romela Irene Ramos Breakdown of academic impact, for papers by Zsuzsa Bajtay
Rankless by CCL
2026